Quarterly Results Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Net Sales
256.99
218.25
244.40
207.47
197.99
210.42
217.68
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
256.99
218.25
244.40
207.47
197.99
210.42
217.68
Raw Material Cost
111.26
86.22
95.37
93.41
76.61
97.41
100.01
Purchase of Finished goods
18.21
20.20
2.26
20.57
13.53
19.03
11.82
(Increase) / Decrease In Stocks
-16.01
-4.76
20.42
-22.10
9.29
-2.25
3.09
Employee Cost
36.14
35.94
33.35
31.00
28.24
29.76
27.51
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.01
0.00
0.01
0.01
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
62.95
45.86
49.52
43.25
49.23
36.67
33.76
Total Expenditure (Excl Depreciation)
212.55
183.46
200.92
166.14
176.90
180.63
176.20
Operating Profit (PBDIT) excl Other Income
44.44
34.79
43.48
41.33
21.09
29.79
41.48
Other Income
11.16
18.46
8.46
35.45
12.07
15.27
5.04
Operating Profit (PBDIT)
55.60
53.25
51.94
76.78
33.16
45.06
46.52
Interest
2.01
1.49
3.04
5.47
1.68
1.08
3.83
Exceptional Items
0.03
-2.51
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
53.62
49.25
48.90
71.31
31.48
43.98
42.69
Depreciation
8.67
8.35
8.26
8.20
8.04
7.55
6.98
Profit Before Tax
44.95
40.90
40.63
63.11
23.44
36.42
35.71
Tax
7.95
16.12
12.04
18.75
6.79
10.62
10.01
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
37.00
24.78
28.59
44.36
16.65
25.80
25.69
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
37.00
24.78
28.59
44.36
16.65
25.80
25.69
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
1.42
1.51
1.34
1.32
1.11
2.00
1.43
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
35.58
23.27
27.25
43.04
15.54
23.80
24.26
Equity Capital
10.58
10.58
10.56
10.55
10.54
10.54
10.51
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
3.36
2.2
2.58
4.08
1.47
2.26
2.31
Diluted Earnings per share
3.28
2.14
2.54
4.04
1.46
2.27
2.29
Operating Profit Margin (Excl OI)
17.29%
15.94%
17.79%
19.92%
10.65%
14.16%
19.06%
Gross Profit Margin
20.86%
22.57%
20.01%
34.37%
15.9%
20.9%
19.61%
PAT Margin
14.4%
11.35%
11.7%
21.38%
8.41%
12.26%
11.8%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Mar 2026 is 29.80% vs -0.07% in Mar 2025
Consolidate Net Profit
YoY Growth in quarter ended Mar 2026 is 128.96% vs 269.84% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Mar 2026 is 110.72% vs -25.61% in Mar 2025
Interest
YoY Growth in quarter ended Mar 2026 is 19.64% vs -9.19% in Mar 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Mar 2026 has improved from Mar 2025
Compare Quarterly Results Of Bliss GVS Pharma With
Figures in Cr
Consolidate Quarterly Results
Change(INR)
Change(%)
Net Sales
256.99
175.19
81.80
46.69%
Other Operating Income
0.00
0.00
0.00
Total Operating income
256.99
175.19
81.80
46.69%
Raw Material Cost
111.26
27.05
84.21
311.31%
Purchase of Finished goods
18.21
35.71
-17.50
-49.01%
(Increase) / Decrease In Stocks
-16.01
3.46
-19.47
-562.72%
Employee Cost
36.14
30.32
5.82
19.20%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
62.95
31.16
31.79
102.02%
Total Expenditure (Excl Depreciation)
212.55
127.70
84.85
66.44%
Operating Profit (PBDIT) excl Other Income
44.44
47.49
-3.05
-6.42%
Other Income
11.16
17.67
-6.51
-36.84%
Operating Profit (PBDIT)
55.60
65.16
-9.56
-14.67%
Interest
2.01
8.46
-6.45
-76.24%
Exceptional Items
0.03
0.00
0.03
Gross Profit (PBDT)
53.62
56.70
-3.08
-5.43%
Depreciation
8.67
9.30
-0.63
-6.77%
Profit Before Tax
44.95
47.40
-2.45
-5.17%
Tax
7.95
10.73
-2.78
-25.91%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
37.00
36.67
0.33
0.90%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
37.00
36.67
0.33
0.90%
Share in Profit of Associates
0.00
0.00
0.00
Minority Interest
1.42
5.06
-3.64
-71.94%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
35.58
31.61
3.97
12.56%
Equity Capital
10.58
46.05
-35.47
-77.02%
Face Value
1.00
10.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
3.36
6.86
-3.50
-51.02%
Diluted Earnings per share
3.28
7.96
-4.68
-58.79%
Operating Profit Margin (Excl OI)
17.29%
27.11%
0.00
-9.82%
Gross Profit Margin
20.86%
32.36%
0.00
-11.50%
PAT Margin
14.40%
20.93%
0.00
-6.53%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 256.99 Cr
in Mar 2026Figures in Cr
QoQ Growth in quarter ended Mar 2026 is 17.75% vs -10.70% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 29.80% vs -0.07% in Mar 2025
Quarterly - Consolidate Net Profit
Consolidate Net Profit 35.58 Cr
in Mar 2026Figures in Cr
QoQ Growth in quarter ended Mar 2026 is 52.90% vs -14.61% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 128.96% vs 269.84% in Mar 2025
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 44.44 Cr
in Mar 2026Figures in Cr
QoQ Growth in quarter ended Mar 2026 is 27.74% vs -19.99% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 110.72% vs -25.61% in Mar 2025
Quarterly - Interest
Interest 2.01 Cr
in Mar 2026Figures in Cr
QoQ Growth in quarter ended Mar 2026 is 34.90% vs -50.99% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 19.64% vs -9.19% in Mar 2025
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 17.29%
in Mar 2026Figures in %
QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025
YoY Growth in quarter ended Mar 2026 has improved from Mar 2025
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
